Analysis of the Molecular Mechanisms of Reepithelialization in Drosophila Embryos.
Authors: Matsubayashi, Y. and Millard, T.H.
Journal: Adv Wound Care (New Rochelle)
Volume: 5
Issue: 6
Pages: 243-250
ISSN: 2162-1918
DOI: 10.1089/wound.2014.0549
Abstract:Significance: The epidermis provides the main barrier function of skin, and therefore its repair following wounding is an essential component of wound healing. Repair of the epidermis, also known as reepithelialization, occurs by collective migration of epithelial cells from around the wound edge across the wound until the advancing edges meet and fuse. Therapeutic manipulation of this process could potentially be used to accelerate wound healing. Recent Advances: It is difficult to analyze the cellular and molecular mechanisms of reepithelialization in human tissue, so a variety of model organisms have been used to improve our understanding of the process. One model system that has been especially useful is the embryo of the fruit fly Drosophila, which provides a simple, accessible model of the epidermis and can be manipulated genetically, allowing detailed analysis of reepithelialization at the molecular level. This review will highlight the key insights that have been gained from studying reepithelialization in Drosophila embryos. Critical Issues: Slow reepithelialization increases the risk of wounds becoming infected and ulcerous; therefore, the development of therapies to accelerate or enhance the process would be a great clinical advance. Improving our understanding of the molecular mechanisms that underlie reepithelialization will help in the development of such therapies. Future Directions: Research in Drosophila embryos has identified a variety of genes and proteins involved in triggering and driving reepithelialization, many of which are conserved in humans. These novel reepithelialization proteins are potential therapeutic targets and therefore findings obtained in Drosophila may ultimately lead to significant clinical advances.
Source: PubMed
Analysis of the Molecular Mechanisms of Reepithelialization in <i>Drosophila</i> Embryos
Authors: Matsubayashi, Y. and Millard, T.H.
Journal: ADVANCES IN WOUND CARE
Volume: 5
Issue: 6
Pages: 243-250
eISSN: 2162-1934
ISSN: 2162-1918
DOI: 10.1089/wound.2014.0549
Source: Web of Science (Lite)
Analysis of the Molecular Mechanisms of Reepithelialization in <i>Drosophila</i> Embryos.
Authors: Matsubayashi, Y. and Millard, T.H.
Journal: Advances in wound care
Volume: 5
Issue: 6
Pages: 243-250
eISSN: 2162-1934
ISSN: 2162-1918
DOI: 10.1089/wound.2014.0549
Abstract:Significance: The epidermis provides the main barrier function of skin, and therefore its repair following wounding is an essential component of wound healing. Repair of the epidermis, also known as reepithelialization, occurs by collective migration of epithelial cells from around the wound edge across the wound until the advancing edges meet and fuse. Therapeutic manipulation of this process could potentially be used to accelerate wound healing. Recent Advances: It is difficult to analyze the cellular and molecular mechanisms of reepithelialization in human tissue, so a variety of model organisms have been used to improve our understanding of the process. One model system that has been especially useful is the embryo of the fruit fly Drosophila, which provides a simple, accessible model of the epidermis and can be manipulated genetically, allowing detailed analysis of reepithelialization at the molecular level. This review will highlight the key insights that have been gained from studying reepithelialization in Drosophila embryos. Critical Issues: Slow reepithelialization increases the risk of wounds becoming infected and ulcerous; therefore, the development of therapies to accelerate or enhance the process would be a great clinical advance. Improving our understanding of the molecular mechanisms that underlie reepithelialization will help in the development of such therapies. Future Directions: Research in Drosophila embryos has identified a variety of genes and proteins involved in triggering and driving reepithelialization, many of which are conserved in humans. These novel reepithelialization proteins are potential therapeutic targets and therefore findings obtained in Drosophila may ultimately lead to significant clinical advances.
Source: Europe PubMed Central